SEC
Filing

SEC Filing Details

Document Details

Form
Filing Date
Feb 16, 2022
Document Date
Jan 25, 2022
Form Description
Amendment to a previously filed 4
Filing Group
3,4,5
Company
Altimmune
Issuer
ALTIMMUNE, INC.
Filer
Drutz David
 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe